| Title |
Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety
|
|---|---|
| Published in |
European Heart Journal - Cardiovascular Pharmacotherapy, April 2020
|
| DOI | 10.1093/ehjcvp/pvaa041 |
| Pubmed ID | |
| Authors |
Login to access the Attention Digest and the Sentiment Analysis related to this output.
An error occurred while generating this chart. Please try again later.
No score history available for this output yet. Please try again later.
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley demographics
The data shown below were compiled from readership statistics for 119 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 119 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 19 | 16% |
| Student > Bachelor | 15 | 13% |
| Other | 9 | 8% |
| Student > Ph. D. Student | 6 | 5% |
| Professor > Associate Professor | 6 | 5% |
| Other | 30 | 25% |
| Unknown | 34 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 37 | 31% |
| Biochemistry, Genetics and Molecular Biology | 10 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 6% |
| Agricultural and Biological Sciences | 6 | 5% |
| Engineering | 2 | 2% |
| Other | 14 | 12% |
| Unknown | 43 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 August 2020.
All research outputs
#11,591,352
of 32,950,043 outputs
Outputs from European Heart Journal - Cardiovascular Pharmacotherapy
#500
of 714 outputs
Outputs of similar age
#182,839
of 427,005 outputs
Outputs of similar age from European Heart Journal - Cardiovascular Pharmacotherapy
#25
of 35 outputs
Altmetric has tracked 32,950,043 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 714 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.0. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 427,005 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.